1 – 6 of 6
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Mechanisms of Action of the DPP-4 Inhibitor Vildagliptin in Man.
- Contribution to journal › Scientific review
- 2010
-
Mark
Vildagliptin add-on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2-year study
- Contribution to journal › Article
- 2009
-
Mark
Vildagliptin improves glucose sensitivity of cells in patients with type 2 diabetes: glucagon response to hypoglycemia
- Contribution to journal › Published meeting abstract
-
Mark
Changes in prandial glucagon levels after 2 years treatment with vildagliptin or glimepiride
(2009) 45th Annual Meeting of the European-Association-for-the-Study-of-Diabetes In Diabetologia 52(Suppl 1). p.798-798
- Contribution to journal › Published meeting abstract
-
Mark
Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy
- Contribution to journal › Article
- 2008
-
Mark
Vildagliptin improves alpha cell glucose sensing in patients with type 2 diabetes
(2008) 44th EASD Annual Meeting of the European Association for the Study of Diabetes In Diabetologia 51(S1). p.36-37
- Contribution to journal › Published meeting abstract
